Relevance of Foxp3+ regulatory T cells for early and late phases of murine sepsis

Immunology

Volumn 146, Issue 1, 2015, Pages 144-156

  Tatura, Roman ^a   Zeschnigk, Michael ^a   Hansen, Wiebke ^a   Steinmann, Joerg ^a   Goncalves Vidigal, Pedrina ^a   Hutzler, Marina ^a   Pastille, Eva ^a   Westendorf, Astrid M ^a   Buer, Jan ^a   Kehrmann, Jan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Pseudomonas aeruginosa; foxp3 TSDR; Methylation; Nrp1; Regulatory T cells

Indexed keywords

CYTOKINE; INTERLEUKIN 6; NEUROPILIN 1; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

AMPLICON; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; DEMETHYLATION; DISEASE COURSE; DNA METHYLATION; FEMALE; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG INFECTION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; STABLE EXPRESSION; T CELL DEPLETION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CECUM; IMMUNOLOGY; LUNG; LYMPHOCYTE DEPLETION; METABOLISM; METHYLATION; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; SEPSIS; SURGERY; TRANSGENIC MOUSE;

ANIMALS; CECUM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION; INTERLEUKIN-6; LUNG; LYMPHOCYTE DEPLETION; MALE; METHYLATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUROPILIN-1; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84938422390     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12490     Document Type: Article

References (47)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50.
2. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-8.
3. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999; 11:153-9.
4. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001; 16:83-96.
5. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
6. Yende S, Angus DC. Long-term outcomes from sepsis. Curr Infect Dis Rep 2007; 9:382-6.
7. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6:353-60.
8. Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 2008; 29:617-25, viii.
9. Tatura R, Zeschnigk M, Adamzik M, Probst-Kepper M, Buer J, Kehrmann J. Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry. PLoS ONE 2012; 7:e49962.
10. + regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003; 31:2068-71.
11. -) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009; 35:678-86.
12. + regulatory T cells in septic mice, thereby leading to an improved survival. Surgery 2012; 151:313-22.
13. + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 2005; 174:7141-6.
14. + regulatory T cells are required for recovery from severe sepsis. PLoS ONE 2013; 8:e65109.
15. + T-regulatory-cells to immune suppression in sepsis. Shock 2007; 27:251-7.
16. - regulatory T cells and inflammatory response and outcome during shock states. Crit Care 2010; 14:R19.
17. + regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 2006; 177:7943-9.
18. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013; 13:862-74.
19. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4:31-6.
20. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500.
21. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009; 9:83-9.
22. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532-41.
23. Bruder D, Probst-Kepper M, Westendorf AM et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004; 34:623-30.
24. + T reg cells. J Exp Med 2012; 209:1723-42, S1.
25. Yadav M, Louvet C, Davini D et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 2012; 209: 1713-22, S1-19.
26. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008; 28:402-13.
27. + conventional T cells. Eur J Immunol 2007; 37:2378-89.
28. Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5:e38.
29. Barnaba V, Schinzari V. Induction, control, and plasticity of Treg cells: the immune regulatory network revised? Eur J Immunol 2013; 43:318-22.
30. Polansky JK, Kretschmer K, Freyer J et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008; 38:1654-63.
31. + T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36:262-75.
32. + regulatory T cells induces a scurfy-like disease. J Exp Med 2007; 204:57-63.
33. + Tregs using the DEREG mouse model. Methods Mol Biol 2011; 707:157-72.
34. Vidigal PG, Musken M, Becker KA et al. Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. PLoS ONE 2014; 9:e92876.
35. Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL. Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp 2011; May 2; (51). pii: 2702.
36. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8:776-87.
37. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6:813-22.
38. + regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10:849-59.
39. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007; 7:875-88.
40. + regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 2008; 216:61-8.
41. - lymphocytes. Crit Care Med 2004; 32:2329-31.
42. Cerdan C, Martin Y, Courcoul M, Brailly H, Mawas C, Birg F, Olive D Prolonged IL-2 receptor α/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 1992; 149:2255-61.
43. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463:808-12.
44. + T cell receptors. Immunity 2004; 21:267-77.
45. + T cells. Immunity 2006; 25:249-59.
46. Murphey ED, Sherwood ER. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 2006; 26:417-24.
47. Berod L, Stuve P, Varela F et al. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on Mycobacterial Burden, but prevents autoimmunity. PLoS ONE 2014; 9:e102804.